Virax Biolabs Group Limit...
(VRAX)
undefined
undefined%
At close: undefined
2.97
-6.31%
Pre-market Jan 07, 2025, 05:49 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 |
| PE Ratio | -0.22 | -1.35 | -121.14 | -317.99 | -258.4 |
| PS Ratio | 9.43 | 863.45 | n/a | 1.67K | 2.07K |
| PB Ratio | 0.27 | 0.81 | -212.41 | -347.22 | -196.01 |
| P/FCF Ratio | -0.2 | -1.7 | -255.86 | -350.75 | -278.01 |
| P/OCF Ratio | -0.24 | -1.77 | -255.86 | -350.75 | -278.01 |
| OCF/S Ratio | -39.94 | -488.23 | n/a | -4.77 | -7.46 |
| Debt / Equity Ratio | n/a | 0.02 | n/a | n/a | -0.72 |
| Quick Ratio | 25.58 | 10.58 | 0.02 | 0.02 | 0.02 |
| Current Ratio | 25.94 | 10.61 | 0.04 | 0.05 | 0.02 |
| Asset Turnover | 0.03 | 0.00 | n/a | 1.32 | 4.42 |
| Interest Coverage | -241.7 | -370.62 | -112.3 | -22.5 | -7.18 |
| Return on Equity (ROE) | -1.25 | -0.6 | 1.75 | 1.09 | 0.76 |
| Return on Assets (ROA) | -1.23 | -0.56 | -35.08 | -6.92 | -35.43 |
| Return on Capital (ROIC) | -1.22 | -0.64 | 1.45 | 0.83 | 0.54 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 32.34% | -15.94% | n/a | -7.62% | 45.81% |
| Net Profit Margin | -4.30K% | -63.75K% | n/a | -525.75% | -802.13% |
| Pretax Profit Margin | -4.31K% | -63.75K% | n/a | -543.46% | -740.38% |
| Operating Profit Margin | -4.15K% | -66.96K% | n/a | -520.55% | -652.05% |
| FCF Margin | -4.74K% | -50.91K% | n/a | -476.65% | -745.54% |
| EBITDA Margin | -4.23K% | -63.57K% | n/a | n/a | -649.58% |